Jason Tardio
Patrimonio netto: 19 228 $ in data 30/06/2026
Patrimonio netto: 19 228 $ in data 30/06/2026
Mr. Jason Tardio is a President & Chief Operating Officer at Immunic, Inc. Mr. Tardio was previously employed as a Chief Operating Officer by Ovid Therapeutics, Inc., a VP & Head-Multiple Sclerosis Franchise by Novartis, Inc., and a General Manager & Managing Director by Biogen, Inc. He received his undergraduate degree from The College of New Jersey and an MBA from St. Joseph's University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMUNIC, INC. 0,01% | 29/06/2026 | 1.251 ( 0,01% ) | 19 228 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNIC, INC. | Presidente | 12/07/2024 |
| Società | Posizione | Fine |
|---|---|---|
| OVID THERAPEUTICS INC. | Direttore operativo | 11/07/2024 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | 01/11/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The College of New Jersey
The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale